Literature DB >> 32187491

P2X7 receptor activity landscape in rat and human glioma cell lines.

Damian Matyśniak1, Natalia Nowak2, Paweł Pomorski1.   

Abstract

P2X7 is a commonly expressed purinergic receptor, which functions as a cation-permeable channel in the plasma membrane. In certain circumstances, the receptor may also form a large transmembrane pore what results in cell death. P2X7 receptors control numerous physiological and pathological cellular processes and their overexpression is often associated with cancer progression. As nucleotides are important signaling molecules in the central nervous system, P2X7 plays also an important but ambiguous role in glioma biology with contrary observations originating from different glioma models. Therefore, the aim of our research was to investigate P2X7 receptor expression and functions in three human (U-87 MG, U-138 MG, U-251 MG) and one rat (C6) glioma cell lines. Although the receptor mRNA and protein were present in all the studied cells, we found profound differences in their level. We also encountered a problem with one human cell lines authenticity (U-87 MG) and excluded it from most of the experiments. Interestingly, there was no clear dependency between P2X7 receptor level, calcium signal and pore formation ability in the studied glioma lines. In U-138 human cell line, the receptor seemed to be inactive, while in U-251 human and C6 rat cell line its activation resulted in calcium influx and large pore formation. However, the viability of studied cells upon the administration of specific P2X7 agonist - BzATP - was not affected for U-138 and U-251, whereas for C6 cells a stimulatory effect was observed. Our results stress the variability of P2X7 signaling in glioma models and the need for future research which would take into account the complicated landscape of the receptor signaling in the brain.

Entities:  

Year:  2020        PMID: 32187491     DOI: 10.18388/abp.2020_2848

Source DB:  PubMed          Journal:  Acta Biochim Pol        ISSN: 0001-527X            Impact factor:   2.149


  5 in total

1.  P2X7 receptors and glioma cells.

Authors:  Leticia Scussel Bergamin
Journal:  Purinergic Signal       Date:  2020-09-01       Impact factor: 3.765

2.  Inhibition of purinergic P2X receptor 7 (P2X7R) decreases granulocyte-macrophage colony-stimulating factor (GM-CSF) expression in U251 glioblastoma cells.

Authors:  Matthew Drill; Kim L Powell; Liyen Katrina Kan; Nigel C Jones; Terence J O'Brien; John A Hamilton; Mastura Monif
Journal:  Sci Rep       Date:  2020-09-09       Impact factor: 4.379

Review 3.  Structure-activity features of purines and their receptors: implications in cell physiopathology.

Authors:  Mauricio Díaz-Muñoz; Rolando Hernández-Muñoz; Armando Butanda-Ochoa
Journal:  Mol Biomed       Date:  2022-01-26

4.  P2X7 receptor: the regulator of glioma tumor development and survival.

Authors:  Damian Matyśniak; Vira Chumak; Natalia Nowak; Artur Kukla; Lilya Lehka; Magdalena Oslislok; Paweł Pomorski
Journal:  Purinergic Signal       Date:  2021-12-29       Impact factor: 3.765

Review 5.  Enteric nervous system and inflammatory bowel diseases: Correlated impacts and therapeutic approaches through the P2X7 receptor.

Authors:  Henrique Inhauser Riceti Magalhães; Patricia Castelucci
Journal:  World J Gastroenterol       Date:  2021-12-14       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.